Genome-wide scan and fine-mapping of rare nonsynonymous associations implicates intracellular lipolysis genes in fat distribution and cardio-metabolic risk
暂无分享,去创建一个
M. McCarthy | Satish Patel | J. Perry | C. A. Glastonbury | K. Small | S. O’Rahilly | S. Sharp | N. Wareham | V. Saudek | I. Barroso | J. Luan | R. Scott | C. Langenberg | R. Zechner | F. Day | E. Wheeler | N. Kerrison | D. Savage | C. Glastonbury | L. Lotta | L. Wittemans | M. Schweiger | I. Stewart | Lina Cai | Chen Li | Liang Dong | K. Lim | M. Van de Streek | Nicholas Bowkera | D. Lucarelli | L. Dong | R. Scott | J. Perry | R. Scott | M. McCarthy | R. Scott | M. McCarthy
[1] Richard G. Lee,et al. Cardiovascular and Metabolic Effects of ANGPTL3 Antisense Oligonucleotides , 2017, The New England journal of medicine.
[2] Geoffrey J. Barton,et al. Jalview Version 2—a multiple sequence alignment editor and analysis workbench , 2009, Bioinform..
[3] G. Yancopoulos,et al. Effect of a monoclonal antibody to PCSK9 on LDL cholesterol. , 2012, The New England journal of medicine.
[4] M. Birnbaum,et al. The Role of PDE3B Phosphorylation in the Inhibition of Lipolysis by Insulin , 2015, Molecular and Cellular Biology.
[5] Johannes Söding,et al. The MPI bioinformatics Toolkit as an integrative platform for advanced protein sequence and structure analysis , 2016, Nucleic Acids Res..
[6] M. DePristo,et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.
[7] C A Emdin,et al. Apfeltyp erhöht Diabetes- und KHK-Risiko , 2017, DMW - Deutsche Medizinische Wochenschrift.
[8] S. O’Rahilly,et al. Genetic syndromes of severe insulin resistance. , 2011, Endocrine reviews.
[9] J. Granneman,et al. Perilipin Controls Lipolysis by Regulating the Interactions of AB-hydrolase Containing 5 (Abhd5) and Adipose Triglyceride Lipase (Atgl)* , 2009, The Journal of Biological Chemistry.
[10] Marcel Martin. Cutadapt removes adapter sequences from high-throughput sequencing reads , 2011 .
[11] O. Smithies,et al. Hydrops Fetalis, Cardiovascular Defects, and Embryonic Lethality in Mice Lacking the Calcitonin Receptor-Like Receptor Gene , 2006, Molecular and Cellular Biology.
[12] 北村 聖. "The New England Journal of Medicine". , 1962, British medical journal.
[13] Ben M. Webb,et al. Comparative Protein Structure Modeling Using MODELLER , 2007, Current protocols in protein science.
[14] M. Belfort,et al. Targeting Adrenomedullin to Improve Lipid Homeostasis in Diabetic Pregnancies , 2017, The Journal of clinical endocrinology and metabolism.
[15] Cathie Sudlow,et al. Algorithms for the Capture and Adjudication of Prevalent and Incident Diabetes in UK Biobank , 2016, PloS one.
[16] Ralf Herwig,et al. Analyzing and interpreting genome data at the network level with ConsensusPathDB , 2016, Nature Protocols.
[17] Frank Eisenhaber,et al. Fat Mobilization in Adipose Tissue Is Promoted by Adipose Triglyceride Lipase , 2004, Science.
[18] R. Zechner,et al. A Peptide Derived from G0/G1 Switch Gene 2 Acts as Noncompetitive Inhibitor of Adipose Triglyceride Lipase* , 2014, The Journal of Biological Chemistry.
[19] S. Yusuf,et al. Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study , 2005, The Lancet.
[20] F. Kronenberg,et al. Investigation and Functional Characterization of Rare Genetic Variants in the Adipose Triglyceride Lipase in a Large Healthy Working Population , 2010, PLoS genetics.
[21] A. Butterworth,et al. Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data , 2013, Genetic epidemiology.
[22] Ben M. Webb,et al. Comparative Protein Structure Modeling Using MODELLER , 2016, Current protocols in bioinformatics.
[23] P. Munroe,et al. Genetic Evidence for a Normal-Weight “Metabolically Obese” Phenotype Linking Insulin Resistance, Hypertension, Coronary Artery Disease, and Type 2 Diabetes , 2014, Diabetes.
[24] Tanya M. Teslovich,et al. Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease , 2017, The New England journal of medicine.
[25] J. Danesh,et al. Association analyses based on false discovery rate implicate new loci for coronary artery disease , 2017, Nature Genetics.
[26] N Slimani,et al. Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study , 2011, Diabetologia.
[27] J. M. Suh,et al. Endocrinization of FGF1 produces a neomorphic and potent insulin sensitizer , 2014, Nature.
[28] Tom R. Gaunt,et al. The UK10K project identifies rare variants in health and disease , 2016 .
[29] Raquel S. Sevilla,et al. Exome-wide association study of plasma lipids in >300,000 individuals , 2017, Nature Genetics.
[30] M. McCarthy,et al. Common Genetic Variants Highlight the Role of Insulin Resistance and Body Fat Distribution in Type 2 Diabetes, Independent of Obesity , 2014, Diabetes.
[31] Inês Barroso,et al. Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance , 2016, Nature Genetics.
[32] Andrew D. Johnson,et al. Multiethnic genome-wide meta-analysis of ectopic fat depots identifies loci associated with adipocyte development and differentiation , 2016, Nature Genetics.
[33] Inês Barroso,et al. Genetic Predisposition to an Impaired Metabolism of the Branched-Chain Amino Acids and Risk of Type 2 Diabetes: A Mendelian Randomisation Analysis , 2016, PLoS medicine.
[34] J. Danesh,et al. A comprehensive 1000 Genomes-based genome-wide association meta-analysis of coronary artery disease , 2016 .
[35] S. O’Rahilly,et al. Perilipin deficiency and autosomal dominant partial lipodystrophy. , 2011, The New England journal of medicine.
[36] D. Gaudet,et al. Targeting APOC3 in the familial chylomicronemia syndrome. , 2014, The New England journal of medicine.
[37] T. Izumi,et al. Activin Receptor-Like Kinase 7 Suppresses Lipolysis to Accumulate Fat in Obesity Through Downregulation of Peroxisome Proliferator–Activated Receptor γ and C/EBPα , 2012, Diabetes.
[38] B. Nordestgaard,et al. Loss-of-function mutations in APOC3 and risk of ischemic vascular disease. , 2014, The New England journal of medicine.
[39] D. Gaudet,et al. ANGPTL3 Inhibition in Homozygous Familial Hypercholesterolemia. , 2017, The New England journal of medicine.
[40] Michael Boehnke,et al. LocusZoom: regional visualization of genome-wide association scan results , 2010, Bioinform..
[41] M. Schulze,et al. General and abdominal adiposity and risk of death in Europe. , 2008, The New England journal of medicine.
[42] P. Visscher,et al. GCTA: a tool for genome-wide complex trait analysis. , 2011, American journal of human genetics.
[43] G. Shulman,et al. Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. , 2000, The Journal of clinical investigation.
[44] Jonathan C. Cohen,et al. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. , 2006, The New England journal of medicine.
[45] J. M. Suh,et al. A PPARγ-FGF1 axis is required for adaptive adipose remodelling and metabolic homeostasis , 2012, Nature.
[46] Sekar Kathiresan,et al. Genetic Association of Waist-to-Hip Ratio With Cardiometabolic Traits, Type 2 Diabetes, and Coronary Heart Disease , 2017, JAMA.
[47] F. Karpe,et al. Biology of upper-body and lower-body adipose tissue—link to whole-body phenotypes , 2015, Nature Reviews Endocrinology.
[48] H. Burdett. Antisense inhibition of apolipoprotein C-III in patients with hypertriglyceridemia , 2016, Annals of clinical biochemistry.
[49] R. Evans,et al. FGF1 — a new weapon to control type 2 diabetes mellitus , 2017, Nature Reviews Endocrinology.
[50] H. Hakonarson,et al. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.
[51] Tamara S. Roman,et al. New genetic loci link adipose and insulin biology to body fat distribution , 2014, Nature.
[52] R. Zechner,et al. Cytosolic lipolysis and lipophagy: two sides of the same coin , 2017, Nature Reviews Molecular Cell Biology.
[53] Thomas R. Gingeras,et al. STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..
[54] Jonathan C. Cohen,et al. Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia. , 2010, The New England journal of medicine.
[55] Robert A. Edwards,et al. Quality control and preprocessing of metagenomic datasets , 2011, Bioinform..
[56] Jake K. Byrnes,et al. Bayesian refinement of association signals for 14 loci in 3 common diseases , 2012, Nature Genetics.
[57] G. Kempermann. Faculty Opinions recommendation of Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. , 2015 .
[58] He Zhang,et al. Loss-of-function mutations in APOC3, triglycerides, and coronary disease. , 2014, The New England journal of medicine.
[59] John H. Zhang,et al. Efficacy and Safety of Cilostazol Therapy in Ischemic Stroke: A Meta-analysis. , 2015, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[60] S. Kathiresan. A PCSK9 missense variant associated with a reduced risk of early-onset myocardial infarction. , 2008, The New England journal of medicine.
[61] Mark Woodward,et al. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. , 2011, Lancet.
[62] Peter Kraft,et al. Adjusting for heritable covariates can bias effect estimates in genome-wide association studies. , 2015, American journal of human genetics.
[63] Kenny Q. Ye,et al. An integrated map of genetic variation from 1,092 human genomes , 2012, Nature.
[64] Chris Cain. ALK7's obese functions , 2014 .
[65] Peter Johnson,et al. Prediction of single‐nucleotide substitutions that result in exon skipping: identification of a splicing silencer in BRCA1 exon 6 , 2011, Human mutation.
[66] P. Donnelly,et al. Genome-wide genetic data on ~500,000 UK Biobank participants , 2017, bioRxiv.
[67] J. Danesh,et al. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies , 2011, The Lancet.
[68] B. Berger,et al. Efficient Bayesian mixed model analysis increases association power in large cohorts , 2014, Nature Genetics.
[69] Tom R. Gaunt,et al. Causal Associations of Adiposity and Body Fat Distribution With Coronary Heart Disease, Stroke Subtypes, and Type 2 Diabetes Mellitus: A Mendelian Randomization Analysis , 2017, Circulation.
[70] E. Degerman,et al. From PDE3B to the regulation of energy homeostasis. , 2011, Current opinion in pharmacology.
[71] Jing Wang,et al. CrossMap: a versatile tool for coordinate conversion between genome assemblies , 2014, Bioinform..
[72] R. Collins,et al. Genetic variants associated with Lp(a) lipoprotein level and coronary disease. , 2009, The New England journal of medicine.
[73] S. Raychaudhuri. Mapping Rare and Common Causal Alleles for Complex Human Diseases , 2011, Cell.
[74] D. Mikhailidis,et al. Cilostazol for intermittent claudication. , 2014, The Cochrane database of systematic reviews.
[75] Y. Sakata,et al. A novel mutation in PNPLA2 causes neutral lipid storage disease with myopathy and triglyceride deposit cardiomyovasculopathy: A case report and literature review , 2014, Neuromuscular Disorders.
[76] N. Day,et al. EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. , 1999, British journal of cancer.
[77] Alex P. Reiner,et al. Loss-of-Function Mutations in APOC 3 , Triglycerides , and Coronary Disease , 2014 .
[78] R. Frikke-Schmidt,et al. Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease , 2014 .
[79] Jun S. Liu,et al. The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans , 2015, Science.
[80] D. Gaudet,et al. Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia. , 2015, The New England journal of medicine.
[81] Tanya M. Teslovich,et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes , 2012, Nature Genetics.
[82] D. Turnbull,et al. The phenotypic spectrum of neutral lipid storage myopathy due to mutations in the PNPLA2 gene , 2011, Journal of Neurology.
[83] J. Danesh,et al. ANGPTL3 Deficiency and Protection Against Coronary Artery Disease. , 2017, Journal of the American College of Cardiology.
[84] P. Elliott,et al. UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age , 2015, PLoS medicine.
[85] S. Crooke,et al. Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials , 2016, The Lancet.
[86] J. Granneman,et al. Novel Pharmacological Probes Reveal ABHD5 as a Locus of Lipolysis Control in White and Brown Adipocytes , 2017, The Journal of Pharmacology and Experimental Therapeutics.
[87] C. Béroud,et al. Human Splicing Finder: an online bioinformatics tool to predict splicing signals , 2009, Nucleic acids research.
[88] Richard Durbin,et al. Gene-gene and gene-environment interactions detected by transcriptome sequence analysis in twins , 2014, Nature Genetics.
[89] S. Bernard,et al. Dynamics of human adipose lipid turnover in health and metabolic disease , 2011, Nature.
[90] Kristin G Ardlie,et al. Genetic Analysis in UK Biobank Links Insulin Resistance and Transendothelial Migration Pathways to Coronary Artery Disease , 2017, Nature Genetics.
[91] Anders Albrechtsen,et al. Weighting sequence variants based on their annotation increases power of whole-genome association studies , 2016, Nature Genetics.
[92] Giovanni Malerba,et al. Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes , 2017, Nature Genetics.
[93] M. Lathrop,et al. The gene encoding adipose triglyceride lipase (PNPLA2) is mutated in neutral lipid storage disease with myopathy , 2007, Nature Genetics.
[94] M. Gerstein,et al. AlleleSeq: analysis of allele-specific expression and binding in a network framework , 2011, Molecular systems biology.
[95] E. Bertini,et al. Neutral Lipid Storage Diseases: clinical/genetic features and natural history in a large cohort of Italian patients , 2017, Orphanet Journal of Rare Diseases.
[96] Jeffrey R O'Connell,et al. Null mutation in hormone-sensitive lipase gene and risk of type 2 diabetes. , 2014, The New England journal of medicine.
[97] P. Arner,et al. Adipose tissue and metabolic alterations: regional differences in fat cell size and number matter, but differently: a cross-sectional study. , 2014, The Journal of clinical endocrinology and metabolism.
[98] Gaston H. Gonnet,et al. The OMA orthology database in 2015: function predictions, better plant support, synteny view and other improvements , 2014, Nucleic Acids Res..
[99] Alan M. Kwong,et al. A reference panel of 64,976 haplotypes for genotype imputation , 2015, Nature Genetics.
[100] Eric Boerwinkle,et al. Sequence Variations in PCSK 9 , Low LDL , and Protection against Coronary Heart Disease , 2006 .
[101] Tanya M. Teslovich,et al. Discovery and refinement of loci associated with lipid levels , 2013, Nature Genetics.
[102] R. Zechner,et al. Development of small molecule inhibitors targeting adipose triglyceride lipase , 2013, Nature chemical biology.
[103] C. Diwoky,et al. Pharmacological inhibition of adipose triglyceride lipase corrects high-fat diet-induced insulin resistance and hepatosteatosis in mice , 2017, Nature Communications.
[104] Samuel E. Jones,et al. Genetic Evidence for a Link Between Favorable Adiposity and Lower Risk of Type 2 Diabetes, Hypertension, and Heart Disease , 2016, Diabetes.
[105] A. Garg. Acquired and inherited lipodystrophies. , 2004, The New England journal of medicine.
[106] R. BailénAlmorox. Effect of a monoclonal antibody to PCSK9 on LDL cholesterol , 2012 .
[107] S. O’Rahilly,et al. Human Frame Shift Mutations Affecting the Carboxyl Terminus of Perilipin Increase Lipolysis by Failing to Sequester the Adipose Triglyceride Lipase (ATGL) Coactivator AB-hydrolase-containing 5 (ABHD5)* , 2011, The Journal of Biological Chemistry.
[108] Mary E. Haas,et al. Analysis of predicted loss-of-function variants in UK Biobank identifies variants protective for disease , 2018, Nature Communications.
[109] R. Zechner,et al. Measurement of lipolysis. , 2014, Methods in enzymology.
[110] T. Consortium. Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study , 2011 .